Neuro-ophthalmology
Studying vision problems related to the nervous system
,
Our researchers aim to apply the latest scientific understanding to the clinical care of patients with neurological diseases affecting the eye.
Through collaborations with national and international partners, we seek to better understand the relationship between neurological conditions and visual impairment, specifically in the areas of optic neuropathy, concussion and trauma and neuro-inflammation.
Optic neuropathies cause loss of vision, often in younger patients. Optic disc drusen, for example, affects 2% of those with European heritage and can cause progressive loss of peripheral vision.
Autosomal dominant optic atrophy is an inherited condition that also causes slowly progressive loss of vision often starting to be noticeable in the third decade of life.
With this project we aim to look for ophthalmic biomarkers of chronic traumatic encephalopathy.
We're working with the neuro-inflammation group at the Brain and Mind Centre, to provide visual assessment and input into research on diseases of neuro-inflammation.
Patients may present to Save Sight Institute with optic neuritis as the first manifestation of a more generalised neuro-inflammatory condition such as multiple sclerosis, neuromyelitis optica or anti-MOG disease.
We provide visual information and collect required blood samples. We also contribute work on multifocal visual evoked potentials and MRI changes.
The dedicated Optic Neuritis clinic continues to study patients with Optic Neuritis (inflammation of the optic nerve). Optic neuritis can be associated with Multiple Sclerosis (MS) and other neurological inflammatory diseases. We are now working in conjunction with Dr Sudarshi Ramanathan and Prof Fabienne Brilot, looking at the rates of anti-MOG antibodies in clinically isolated syndrome and uveitis.
Our team continues to work on Giant Cell Arteritis (GCA), we have been assisting Dr Anthony Sammel (PhD) in his ongoing research in this area.
Idiopathic intracranial hypertension (IIH) is a condition that affects women of child-bearing age, particularly those who have gained weight.
With increasing rates of obesity, this condition is becoming more common. IIH causes headaches, vision loss and cognitive changes, affecting women at the peak of their child-bearing and working years.
Formalised clinical trials with dedicated dieticians and intensive calorie restrictions have been shown to treat IIH. However, these resources are not available in a standard ophthalmic clinic. We are thus assessing simple, patient-driven weight loss efforts, to see if IIH can be managed and reversed.
Email
Submit your enquiry
Mailing address
South Block, Sydney Eye Hospital
8 Macquarie Street
Sydney, NSW 2000